Do the Pharmacopœal Preparations of Ergot Contain Any Active Principles?

Clark AJ. · 1927

Read Do the Pharmacopœal Preparations of Ergot Contain Any Active Principles? by Clark AJ. (1927) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5424030.txt.

Introduction

Clark asks whether the official ergot preparations sold to doctors hold any real active drug. The paper was read to the Edinburgh Obstetrical Society. Ergot is a fungus that grows on rye. It has poisoned whole districts in past centuries. It also speeds labour by tightening the womb. Chemists had isolated strong alkaloids from the fungus. They held that the drug's value rests on those alkaloids.

Yet the British Pharmacopoeia preparations seemed to hold only traces of them. On lab logic, the products should be near inert. Clinicians had still used them for thirty years without complaint. Clark calls that clash unsatisfactory. A new pharmacopoeia was in prospect. He urges lab workers and clinicians to settle the question together. His paper lays out the lab evidence for doctors to judge. It is a plea for joint testing, not a report of new findings.

Catalog record

CREATORClark AJ.
YEAR1927
COLLECTIONPAPERS
FORMATTXT
FILE SIZE32 KB
LICENSEPublic Domain
RIGHTSPUBLIC DOMAIN
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC5424030

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Do the Pharmacopœal Preparations of Ergot Contain Any Active Principles? *Read 9th March 1927. By A. J. Clark Published in: Transactions. Edinburgh Obstetrical Society DO THE PHARMACOPCEAL PREPARATIONS OF ERGOT CONTAIN ANY ACTIVE PRINCIPLES?* By Prof. A. J. CLARK, F.R.C.P. By invitation. I MUST start by confessing that I have no new discoveries to lay before this meeting and that my paper is really an effort at propaganda, for I desire to enlist your help in clearing up a remarkably unsatisfactory situation. The position is that the laboratory workers, that is to say, the chemists and pharma- cologists, agree that ergot contains certain specific active alkaloids, and they believe that these are the substances upon which its therapeutic value in obstetrics depends, but they also agree that the preparations of ergot described in the British Pharmacopoeia cannot contain more than traces of these active alkaloids, and hence they conclude that these said preparations must be almost completely inert. On the other hand, these B. P. preparations have been used for at least thirty years without complaint by clinicians. Since a new pharmacopoeia is likely to be prepared in the near future, it is obviously of public interest that this uncertainty should be settled. This can only be done by co-operation between laboratory and clinical workers. I propose to-night to set before you the evidence in favour of the beliefs held by the laboratory workers, and I trust that you will criticise these in the light of your clinical experience of the drug. The very powerful and curious toxic actions of ergot have been known only too well since prehistoric times, since epidemics due to the eating of ergotised rye have repeatedly produced widespread poisoning in Europe. The earliest recorded epidemic was in the ninth century and several epidemics occurred as late as the last half of the nineteenth century. Before the advent of steam transport the inhabitants of large districts. after bad summers frequently had the choice of either eating ergotised rye or else starving, and hence epidemics of ergotism frequently killed or maimed large numbers. Two distinct types of epidemics occurred, namely (i) the * Read 9th March 1927. OBST. I?9 Professor A. J. Clark convulsive type in which the initial symptoms were diarrhoea and vomiting, and muscular spasms resembling tetany ; these developed to epileptiform convulsions with tonic contractions of limbs; (2) the gangrenous type, which commenced with diarrhoea and vomiting followed by gangrene of the extremities, the fingers and ears being first affected. Frequently whole limbs were lost, and there are accounts of individuals reduced to a trunk and head. Usually the symptoms in all the cases of any particular epidemic conformed to one or other of these two types. The occurrence of two distinct types of poisoning indicates that there must be several active principles in ergot and that the composition of the drug must vary from year to year. Abortion occurred frequently in epidemics of ergotism, and the oxytoxic action of ergot was recognised very early. In 1582, Adam Lonicer of Frankfurt mentioned the use of ergot in hastening labour. In the seventeenth century it was used extensively for the purpose of criminal abortion, and in con- sequence its employment was forbidden by many authorities. In the eighteenth century, however, it was reintroduced as a therapeutic agent in obstetrics. The nature of the action of ergot was established very early, for instance, Buchheim, in 1859, stated: "Ergot is used very frequently to stimulate the contractions of the uterus when there is prolonged weakness of the pains. Violent and pro- longed pains usually commence ten to twenty minutes after administration of the drug, and delivery soon follows. This can only happen in safety when there is no mechanical obstruction, due to such causes as contracted pelvis, abnormal position, etc., and when the cervix is fully dilated, although the pains are not strong enough to produce delivery. In other conditions the violent contractions can easily produce injury to the uterus, and therefore many doctors dislike the use of the drug. . . . The activity of ergot is very unequal, from various causes. Ergot from very wet places is inactive. Preparations lose activity on keeping and no method of producing a stable preparation has been discovered. It is best to give the drug as powder 10 to 20 grains every fifteen to twenty minutes until the desired action occurs." This is a remarkably clear summary of the chief actions of the drug, and there is little to be added to this statement to-day. Ergot is therefore a drug with a definite therapeutic action which has long been recognised. Pharmacopoeal Preparations of Ergot Chemistry of Ergot.?A great deal of work was devoted to isolation of the active principles of ergot last century. The outstanding discoveries were as follows:? In 1874, Buchheim suggested that the action of ergot was due to the "putrid and septic" substances it contained, and, in 1875, Tanret isolated a pure crystalline alkaloid ergotinin. In 1884, Kobert however showed that ergotinin was pharma- cologically inert. In 1906, Barger and Carr1 isolated the alkaloid ergotoxin. Barger and Dale2 proved that this ergo- toxin produced all the chief pharmacological actions of ergot, which were rise of blood pressure, contraction of the uterus, and paralysis of the sympathetic. Kraft identified ergotoxin as the hydrate of Tanret's ergotinin, and the formula C35H41OcN5 was finally adopted. Further research by Barger, Dale, and others showed that in addition to its specific alkaloid, ergot contained a series of non-specific amines, substances which can be produced by the putrefactive breakdown of most proteins. The most important of these amines were (i) tyramin (/-hydroxy-phenyl ethyl amine), derived from the amino-acid tyrosin; and (ii) histamin ; (/3 - amino - azolylethylamin) derived from the amino - acid histidin. Other substances were?agmatin, similarly derived from arginin, cholin, acetylcholin, methylamin, ethylamin, etc., and numerous other substances, one of which, namely ergosterol, has suddenly acquired importance as the precursor or provitamin of vitamin D. Finally, Stoll, in 1922, isolated a new specific alkaloid ergotamin (C33H35N505). This substance had apparently exactly the same pharmacological action as ergotoxin (Dale and Spiro).3 I am unaware of the relative amounts of these two alkaloids present in ergot. For practical purposes, therefore, the active principles of ergot can be divided into (a) the specific alkaloids ergotoxin and ergotamin which occur only in ergot; and (b) a host of other non - specific substances, products of protein break- down, etc. Obviously the first question that arises is the relative importance of these two groups as regards the therapeutic use of ergot. Now the first obvious fact about ergot is that it produces its specific effects when given by mouth. This is evidenced both by the history of ergotism and everyday OBST. Ill h 2 Professor A. J. Clark experience in therapeutics. This alone proves that most of the non-specific amines are of little importance as regards the therapeutic action of ergot. For example, in 1910, the writer4 investigated the action of tyramin on man and found that 15 mgrms. of tyramin produced a distinct rise of blood pressure when given hypodermically, but that 200 mgrms. by mouth produced only a doubtful action. The action

Read the complete text